Experts assess link between statin use, diabetes

05/23/2013 | HealthDay News

Canadian researchers found atorvastatin was associated with a 22% increased risk of new-onset diabetes, while patients who took rosuvastatin or simvastatin had an 18% and 10% increased risk of the condition, respectively, compared with patients taking pravastatin. Pravastatin, fluvastatin and lovastatin were tied to a slightly lower diabetes risk, researchers reported in BMJ.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Senior Manager, Clinical Affairs - Advanced Technology
Edwards Lifesciences
Irvine, CA
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park